Fungal Infection Susceptibility Study

Fungal Infection Susceptibility

Recruiting Observational Study
Cryptococcal Infection Cryptococcal Pneumonia Pulmonary Cryptococcosis Cryptococcal Meningitis Cryptococcosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 99
Sex
Any
Study type
Observational
Participants needed
800 (estimated)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Who this trial is looking for

This trial is looking for adults with cryptococcal infections and their family members. Participants will provide samples for research and may undergo genetic testing.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have cryptococcal infection as confirmed by medical records.
  • I am over 18 years old.
  • I have a primary physician outside of the NIH.
  • I agree to genetic testing and allow my samples to be stored for future research.
  • I am a genetic relative of a patient enrolled in this study.

You may not be able to join if

  • I have HIV or cancer.
  • I receive chemotherapy or immunosuppressants.
  • I have a history of recurrent infections.
  • I am pregnant.
  • I have heart, lung, kidney disease, or bleeding disorders.
  • I have conditions that may interfere with immune evaluation.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The protocol will be carried out in accordance with International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Good Clinical Practice (GCP) and the following United States Code of Federal Regulations (CFR) applicable to clinical studies: 45 CFR Part 46, 21 CFR Part 50, 21 CFR Part 56, 21 CFR Part 312, and/or 21 CFR Part 812. NIH-funded investigators …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: Patients Patients must: 1. Have cryptococcosis as determined by information collected from their medical records, telephone interviews, or from a referring physician: * histopathology showing cryptococci; or * culture of C. neoformans or C. gattii * a positive cryp…
Contacts

Peter R Williamson, M.D.

(301) 443-8339

williamsonpr@mail.nih.gov

CONTACT